John Gordon Freund

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: Collegium Pharmaceutical Inc., 3 years.

3 years · Since 2023
3 years · Since 2023
SI-BONE Inc. Director
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 4, 2026 SI-BONE Inc. Grant or award +10,957 — —
May 18, 2026 Collegium Pharmaceutical Inc. Open-market sale −20 $34.05 $681
May 15, 2026 Collegium Pharmaceutical Inc. Option exercise +8,700 $16.49 $143,463
May 15, 2026 Collegium Pharmaceutical Inc. Open-market sale −4,127 $34.54 $142,547
May 14, 2026 Collegium Pharmaceutical Inc. Grant or award +8,741 — —
Aug 8, 2025 Collegium Pharmaceutical Inc. Open-market sale −11,659 $34.36 $400,603
Aug 8, 2025 SI-BONE Inc. Open-market sale −12,132 $15.99 $193,991
Jun 9, 2025 Collegium Pharmaceutical Inc. Option exercise +15,000 $13.45 $201,750
Jun 9, 2025 Collegium Pharmaceutical Inc. Open-market sale −6,601 $30.62 $202,123
Jun 5, 2025 SI-BONE Inc. Grant or award +8,675 — —
May 15, 2025 Collegium Pharmaceutical Inc. Grant or award +9,791 — —
Jun 26, 2024 SI-BONE Inc. Grant or award +8,791 — —
May 16, 2024 Collegium Pharmaceutical Inc. Grant or award +7,693 — —
Aug 9, 2023 SI-BONE Inc. Open-market sale −30,000 $20.54 $616,200
Jun 9, 2023 SI-BONE Inc. Grant or award +4,866 — —

Questions about John Gordon Freund

What boards is John Gordon Freund on?

John Gordon Freund sits on the boards of Collegium Pharmaceutical Inc., SI-BONE Inc. and Sutro Biopharma Inc.

How long has John Gordon Freund served on boards?

Our records show at least 10 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.